These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 4281483)
41. Quantification of chorea in Huntington's disease by power spectral analysis. Weitzman DO; Rosfnfeld C; Korenyl C; Whittier JR Dis Nerv Syst; 1976 May; 37(5):264-8. PubMed ID: 131027 [TBL] [Abstract][Full Text] [Related]
42. Reserpine: cause and treatment of oral-facial dyskinesia. Wolf SM Bull Los Angeles Neurol Soc; 1973 Apr; 38(2):80-4. PubMed ID: 4702802 [No Abstract] [Full Text] [Related]
43. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Frank S; Ondo W; Fahn S; Hunter C; Oakes D; Plumb S; Marshall F; Shoulson I; Eberly S; Walker F; Factor S; Hunt V; Shinaman A; Jankovic J Clin Neuropharmacol; 2008; 31(3):127-33. PubMed ID: 18520979 [TBL] [Abstract][Full Text] [Related]
44. Editorial: Dopamine and G.A.B.A. in Huntington's chorea. Lancet; 1974 Nov; 2(7889):1122-3. PubMed ID: 4139415 [No Abstract] [Full Text] [Related]
45. Letter: Treatment of Huntington's chorea. Candelise L; Faglioni P; Spinnler H; Vignolo LA N Engl J Med; 1973 Nov; 289(22):1201. PubMed ID: 4271092 [No Abstract] [Full Text] [Related]
46. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Guay DR Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622 [TBL] [Abstract][Full Text] [Related]
47. Effect of tetrabenazine on extrapyramidal movement disorders. Dalby MA Br Med J; 1969 May; 2(5654):422-3. PubMed ID: 4238453 [TBL] [Abstract][Full Text] [Related]
49. Clozapine therapy for Parkinson's disease and other movement disorders. Pfeiffer C; Wagner ML Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623 [TBL] [Abstract][Full Text] [Related]
50. Treatment of multiple tics and the Tourette syndrome. Gillies DR; Forsythe WI Dev Med Child Neurol; 1984 Dec; 26(6):830-3. PubMed ID: 6151532 [No Abstract] [Full Text] [Related]
51. The pathophysiology of movement disorders. Marsden CD Neurol Clin; 1984 Aug; 2(3):435-59. PubMed ID: 6241955 [TBL] [Abstract][Full Text] [Related]
52. [Pathogenesis and treatment of tic-type hyperkinesis in children]. Bondarenko ES; Malyshev IuI; Blagosklonov AV; Lebedev VN Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(10):1449-56. PubMed ID: 6947655 [TBL] [Abstract][Full Text] [Related]
53. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Savani AA; Login IS Neurology; 2007 Mar; 68(10):797; author reply 797. PubMed ID: 17339599 [No Abstract] [Full Text] [Related]
54. [The use of levodopa in diseases other than Parkinsonism]. Barbeau A Union Med Can; 1972 May; 101(5):849-52. PubMed ID: 4666887 [No Abstract] [Full Text] [Related]
55. [Abnormal involuntary movements in the elderly and their treatment (author's transl)]. Delwaide PJ; Desseilles M Sem Hop; 1978 Nov 18-25; 54(41-42):1247-9. PubMed ID: 32624 [TBL] [Abstract][Full Text] [Related]
56. Persistent phenothiazine dyskinesia treated with tetrabenazine. Godwin-Austen RB; Clark T Br Med J; 1971 Oct; 4(5778):25-6. PubMed ID: 4938245 [TBL] [Abstract][Full Text] [Related]
57. Drugs and motor functions. Gordon N Dev Med Child Neurol; 1971 Jun; 13(3):384-6. PubMed ID: 4398415 [No Abstract] [Full Text] [Related]
58. The pathogensis and medical treatment of extrapyramidal disease. Calne DB; Eisler T Med Clin North Am; 1979 Jul; 63(4):715-27. PubMed ID: 157413 [No Abstract] [Full Text] [Related]